Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naïve HIV-2-infected patients: The ACHIEV2E collaboration study group

1. Benard, A.
2. Van Sighem, A.
3. Taieb, A.
4. Valadas, E.
5. Ruelle, J.
6. Soriano, V.
7. Calmy, A.
8. Balotta, C.
9. Damond, F.
10. Brun-Vezinet, F.
11. Chene, G.
12. Matheron, S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/CID/CIR123 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus